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Neuromyelitis optica spectrum disorders (NMOSDs) are important autoimmune cen-
tral nervous system (CNS) astrocytopathy causing acute myelitis, optic neuritis (ON), 
and encephalitis associated with significant morbidities and mortality. It is important 
to diagnose NMOSDs early as they are treatable. The majority of NMOSDs patients 
are seropositive for aquaporin-4 IgG (AQP4-IgG) autoantibodies, which target CNS 
aquaporin-4 (AQP4) expressed abundantly in astrocytic foot processes. We report the 
novel observation of orbital masses containing ectopic lymphoid follicles with germinal 
centres (GC) in two patients with AQP4-IgG-positive NMOSD. Both patients had severe 
extensive myelitis with symptomatic or asymptomatic ON, with the ectopic lymphoid 
structures detected on initial presentation. Histolopathological studies confirmed that 
the orbital masses contained reactive lymphoid follicles with GC containing B cells and 
plasma cells. Our observations support that AQP4-IgG positive NMOSDs patients have 
underlying AQP4 autoimmunity and suggest that ON (symptomatic or asymptomatic) 
may trigger formation of orbital ectopic GC contributing to development of high-affinity 
AQP4-specific memory B  cells and plasma cells, which produce highly pathogenic 
AQP4-IgG.
Keywords: neuromyelitis optica spectrum disorder, aquaporin 4, autoimmunity, ectopic lymphoid structures, 
germinal center
BaCKGRoUND
Neuromyelitis optica spectrum disorders (NMOSD) are central nervous system (CNS) inflamma-
tory disorders (1–3). Relapsing acute neuroinflammation is the clinical course in the majority of 
NMOSD patients characterized by recurrent attacks of unilateral or bilateral optic neuritis (ON) and 
acute myelitis, typically longitudinally extensive transverse myelitis (LETM) (1, 2). The diagnosis of 
NMOSD are greatly facilitated by detection of IgG autoantibodies targeting aquaporin-4 (AQP4) 
(1, 4–6). Aquaporin-4 IgG autoantibodies (AQP4 IgG) are detected in the serum of about 75% of 
patients and are specific for NMOSD (1, 4). AQP4 is a water channel highly expressed in astrocytic 
endfoot processes and plays important roles in CNS water homeostasis (7).
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Neuromyelitis optica spectrum disorders patients seropositive 
for AQP4-IgG have underlying autoimmunity targeting AQP4 
(1, 2). The pathogenetic mechanisms triggering AQP4 autoim-
munity is uncertain, but B  cells certainly play important roles 
(8). CD19+CD27highCD38highCD130− plasmablasts are increased 
in peripheral blood of NMO patients, which secrete AQP4-IgG 
under stimulation by IL-6 (9), and anti-CD20 monoclonal 
antibody (rituximab) is effective in some NMOSD patients (10). 
Germinal centers (GC) in secondary lymphoid organs are impor-
tant sites for production of high-affinity specific antibodies in 
adaptive immunity and high-affinity pathogenic autoantibodies 
in autoimmune diseases. Interestingly, ectopic lymphoid follicles 
(ELF) containing GC are observed in target tissues in autoim-
mune diseases such as lymphofollicular hyperplasia in thymuses 
of early onset myasthenia gravis (11).
Case pReseNtatIoN, LaBoRatoRY 
INVestIGatIoNs, aND DIaGNostIC 
tests
patient 1
A 67-year-old Chinese woman had steroid-refractory immune 
thrombocytopenic purpura treated with splenectomy, hyperten-
sion, diabetes, bilateral glaucoma on regular eyedrops for 7 years 
and benign thyroid tumor resected 8 years ago. She developed 
radicular pain at T6–8 dermatomes followed by bilateral lower 
limb paresthesia and numbness ascending to T2 dermatome, 
paraplegia, and urinary retention over 2 weeks. She had upper 
respiratory tract infection 2  weeks before onset of lower limb 
symptoms. Physical examination confirmed paraplegia, upgo-
ing plantars, and sensory level at T6. MRI spine revealed T2W 
hyperintensity consistent with LETM affecting C6-T6 with mild 
contrast enhancement. CSF analysis revealed mild pleocytosis of 
15 × 106/L (48% neutrophil, 18% lymphocyte, 29% mononuclear 
cells, and 5% eosinophil), normal protein, and glucose levels 
without oligoclonal bands or malignant cells. She was treated 
with intravenous methylprednisolone (IVMP) 1  g daily for 
5 days and gradually improved to walking with frame 4 weeks 
later. Right visual-evoked potential (VEP) latency was prolonged 
to 128  ms and left VEP was normal. Her serum IgG level was 
elevated to 2,590 mg/dL with normal IgA and IgM levels, but no 
monoclonal band was detected. She was seropositive for antinu-
clear antibody (ANA) at 1/40 with minimally elevated anti-ds 
DNA at 37 IU/mL, but seronegative for NMO-IgG (tissue-based 
immunofluorescence).
She reported right eye puffiness for 2  years, which was 
reduced in severity after pulse steroid therapy for myelitis. 
Ophthalmologist’s assessment revealed a right conjunctival mass. 
MRI brain and orbits performed 7 weeks later revealed no cerebral 
abnormalities, but a T1 and T2 hypointense lesion surrounding 
the superior aspect of the right eyeball with heterogeneous, 
predominantly peripheral contrast enhancement, and the left 
eyeball was similarly affected to a lesser extent while the optic 
nerves and extraocular muscle were unremarkable (Figure  1). 
Lymphoma was suspected but she had no palpable lymph node 
or organomegaly. Right conjunctival excisional biopsy performed 
3 months after myelitis onset revealed a circumscribed lymphoid 
lesion consisting of hyperplastic secondary follicles with small 
lymphocytes and plasmacytosis associated with prominent 
interfollicular vasculature. The plasma cells were mature looking, 
and there was no epithelial component. Immunohistochemstry 
confirmed that the GC were BCL2 negative supporting they were 
reactive in nature, and the interfollicular regions contained mod-
erate number of T lymphocytes; the plasma cells were polytypic 
for kappa and lambda light chain with a normal ratio. Cytokeratin 
MNF116 staining confirmed the absence of epithelial element. 
These were suggestive of reactive lymphoid hyperplasia.
Three months later, she developed right homonymous 
hemianopia followed by bilateral lower limb weakness and uri-
nary retention over 6 days. MRI spine showed recurrent myelitis 
lesion over C2-T6. MRI brain showed inflammatory demyelinat-
ing lesions involving the deep and periventricular white matter 
around the left posterior temporal and occipital horn, and part 
of the splenium of corpus callosum, mild right optic atrophy; 
the orbital lesions were similar as on previous MRI. She did not 
improve after IVMP 1 g daily for 5 days, hence, six sessions of 
plasmapheresis were performed and she improved afterward to 
walk with frame. Azathioprine and corticosteroid were initiated 
for prevention of relapses for her NMO-IgG negative NMOSD. 
As repeated, MRI showed similar orbital masses, right orbital 
biopsy through anterior orbitotomy was performed 1 year after 
onset. Histopathological study revealed a circumscribed lym-
phoid lesion consisting of dense infiltrate of mixed lymphoid 
cells and plasma cells, the plasma cells were mature-looking and 
no atypical infiltrate or epithelial component were observed. 
Immunohistochemistry showed mixtures of B and T cells, the 
plasma cells showed no light chain restriction. Consistent with 
the conjunctival biopsy, the overall features were suggestive of 
reactive lymphoid hyperplasia (Figure  3). She subsequently 
developed further recurrent myelitis while on azathioprine 
75  mg daily and refused increase of azathioprine dose due to 
concerns about its side effects. MRI brain repeated a year later 
showed that the nodular lesions were persistent at the superior 
aspects of bilateral eyeballs with some contrast enhancement, 
but reduced in size, and repeated serology detected AQP4-IgG 
by cell-based assay (5). She walked with mild assistance and was 
stable.
patient 2
A 43-year-old Chinese woman with good past health presented 
with rapidly progressive bilateral painless visual loss over 
2 days followed by bilateral lower limb weakness 4 days later. 
Examination revealed bilateral blindness with papilledema and 
paraplegia. Urgent MRI orbits and brain revealed no cerebral 
parenchymal lesion but right orbital mass (Figure  2), MRI 
spine performed 1 week later showed diffuse T2W hyperintense 
lesions with contrast enhancement at C3/4, C6-T1, T2-T4, and 
T7-T9 levels. LP revealed opening pressure of 14 cm water and 
CSF analysis yielded protein 0.75 g/L, glucose 4.7 mmol/L, and 
raised IgG level without OCB or malignant cells. Her serum 
IgG, IgM, complement C3 and C4 levels were normal, but IgA 
was elevated to 477  mg/dL (normal 70–386  mg/dL) without 
monoclonal band. Her serum was positive for AQP4-IgG by 
FIGURe 2 | Coronal MRI of patient 2 showed intraconal orbital mass lesion 
(arrow) with low T2W signal (a) and modest contrast enhancement  
(B) having a 0.9 SUV on 18FDG PET image (e). Coronal MRI more anteriorly 
showed extraconal orbital lesions (short and long arrows) with low T2W 
signals (C) with modest contrast enhancement (D). One of the extraconal 
lesion infiltrated the outer lateral part of the right globe [long arrows in  
(C,D)]. Lacrimal glands were enlarged [arrowheads in (a–D)], and they 
demonstrated low T2W signals with modest contrast enhancement 
suggestive of lymphoid tissue infiltrate.
FIGURe 1 | Axial MRI of patient 1 showed predominately extraconal 
infiltrating soft tissue lesions in both orbits (arrowheads) with significant 
preseptal component, they were hypointense on T1W (a) and T2W (B) 
images with heterogeneous contrast enhancement (C,D).
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were then initiated to prevent relapse. She had improvement in 
vision and lower limb power to grade 3-/5. Azathioprine was 
withdrawn due to liver function derangement and replaced 
by mycophenolate mofetil 1  g BD. Three months after initial 
presentation, she developed recurrent myelitis affecting T6–9 
and conus medullaris regions. She was treated with IVMP 
1  g daily for 5  days and plasmapheresis. Prednisolone was 
gradually tailed down to 15 mg daily. She improved gradually 
to walk with frame 4 months later. Whole-body PET-CT scan 
performed 4  months after clinical onset revealed two small 
eumetabolic enhancing soft tissue masses without significant 
fluorodeoxyglucose uptake in the right orbit (Figure  2E), 
and two prominent eumetabolic cervical lymph nodes, which 
could be reactive; there was no hypermetabolic or destructive 
lesion. She developed further relapse of severe myelitis affect-
ing C1–6 5  months after the last attack. Repeated MRI brain 
revealed no parenchymal lesions and the intraconal lesions 
of right orbit were static and persistent with homogenous 
cell-based assay and ANA at low titer (1/160) without elevated 
anti-dsDNA level. Biopsy of the right orbital mass via orbitotomy 
4 days after symptoms onset revealed that the mass consisted 
of fibrous tissue with lobules of lymphoid infiltrate separated 
by fibrous septa; the infiltrate showed many GC surrounded by 
dense sheets of small lymphocytes (Figure 4). High-endothelial 
venules (HEV) and scattered large activated lymphoid cells 
were observed between the GC. Marginal zone proliferation 
was not discerned and a small number of mature plasma cells 
were seen patchily. There were no sheets of large lymphoid cells, 
Hodgkin cells, or variants. Immunohistochemistry confirmed 
the GC were reactive (BCL2−CD10+BCL6+) and positive for 
B  cell marker CD20 (Figure  4); there was expansion of the 
mantle zone but with moderate number of T  lymphocytes in 
between the follicles, and the B cells in the mantle zone were 
negative for CD5 and CD43. The lymphoid cells were negative 
for cyclinD1 (not supportive of mantle zone lymphoma). The 
T lymphocytes were CD2+3+5+7+ and the CD4:CD8 ratio was 
around 5:1. There were no increased natural killer cells on 
CD56 staining. The plasma cells were prototypical for kappa 
and lambda light chain, and a small number of plasma cells 
were positive for IgG4 (IgG4/IgG ratio ~15%) (Figure  4). 
Although the expanded mantle zone was atypical, the B cells 
in the mantle zone were negative for CD5, CD43, and cyclin 
D1, hence not supportive of mantle cell lymphoma. Biopsy 
of the right lacrimal gland revealed benign gland with patchy 
reactive lymphoid infiltrate, characterized by preserved acinar 
architecture, benign lobules with patchy mild lymphocytic, and 
mature plasma cell infiltration.
She was treated with IVMP 1  g daily for 5  days followed 
by plasmapheresis. Azathioprine and prednisolone (1 mg/kg) 
FIGURe 4 | Histopathological findings of patient 2. The right orbital mass 
consisted of cellular lymphoid nodules separated by hyalinized fibrous septa, 
but in areas, these nodules were coalescing (H&E ×4) (a). The nodules showed 
reactive germinal centers (GC) surrounded by small-sized lymphocytes (H&E 
×20) (B). The lymphocytes did not show cytologic atypia (H&E ×40) (C). CD20 
monoclonal antibody staining revealed that the lymphoid nodules consisted of 
B cells, and the interfollicular B cells were within normal limits (×10) (D). The 
plasma cells are polytypic for kappa (e1) and lambda (e2) light chain (×10) (e). 
Staining with BCL6 and BCL2 antibodies revealed the presence of BCL6 (f1) 
and absence of BCL2 (f2) in the GC (F). Staining with CD5 and cyclinD1 
antibodies revealed that the B cells in the mantle zone were negative for both 
CD5 (g1) and cyclinD1 (g2) in the GC (G). A small number of IgG4 positive 
plasma cells surround the hyperplastic lymphoid follicles (×10) (H).
FIGURe 3 | Histopathological findings of patient 1. The left upper 
eyelid mass showed cellular lymphoid nodules separated by dense 
hyalinized fibrous septa (H&E ×4) (a). The nodules were composed of 
hyperplastic lymphoid follicles surrounded by well formed mantle 
zone and the septa contains mature plasma cells (H&E ×40) (B). 
Mature plasma cells were shown in another area of the septa (H&E 
×40) (C). CD20 monoclonal antibody staining revealed that the 
B cells were confined within the follicles (×10) (D). The plasma cells 
are polytypic for kappa (e1) and lambda (e2) light chain (×10). BCL2 
antibody staining revealed the absence of BCL2 in the germinal 
centers (F). Many of the plasma cells are positive for IgG (G) and a 
fair amount are positive for IgG4 (H) (×10), but the IgG4:IgG ratio is 
less than 40%.
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enhancement. Her vision and left upper limb power improved 
after IVMP and plasmapheresis, but she remained paraplegic. 
MMF was increased to 1.5  g BD and she remained stable; 
however, 4  months later, she decided to switch to rituximab 
for potentially superior efficacy. Rituximab 375 mg/ m2 weekly 
for 4 weeks was intiatied and MMF was tailed down to 1 g BD 
a month later. Unfortunately, she developed fulminant relapse 
of cervical myelitis at C1–2 region with respiratory failure 
2 months later. Despite aggressive treatment including IVMP 
1 g daily for 5 days and plasmapheresis, she succumbed from 
complicating pneumonia.
Written informed consent was obtained from the participants 
for the publication of this case report.
DIsCUssIoN
B cells play important roles in the pathogenesis of AQP4-IgG-
positive NMOSD as their progeny, plasmablasts, and plasma 
cells, produce the pathogenic autoantibodies (8, 9). In addi-
tion, the efficacy of B cell depletion by anti-CD20 monoclonal 
antibody (rituximab) in a significant proportion of NMOSD 
patients implies that other B cell functions besides autoantibody 
production are important in NMOSD pathophysiologies as 
mature plasmablasts and plasma cells do not express CD20 
(8, 9, 12). Antigen presentation to T  cells and secretion of 
proinflammatory cytokines by B  cells are likely important 
pathogenetic mechanisms in NMOSD (8).
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Specific humoral immunity requires B cells contact with the 
specific antigen and interaction with helper T  cells, this occur 
with organization of B and T cells into GC where T and B cells 
interact to allow development of long-lived memory B cells and 
plasma cells capable of producing high-affinity specific antibodies 
(13). In GC, chemokines and cytokines secreted from activated 
T cells, typically T follicular helper (TFH) cells, drive maturation 
and differentiation of B cells with somatic hypermutation, class 
switching, and affinity maturation of immunoglobulins (14, 15). 
Our two patients had orbital mass lesions on presentation of 
LETM or ON rapidly followed by LETM, which were shown to 
be ELF containing GC. ELF are structurally similar to second-
ary lymphoid organs including encapsulated organs such as the 
spleen and lymph nodes, and mucosal-associated lymphoid tissue 
(MALT) such as the tonsils and Peyer’s patches. ELF occur in sites 
of chronic inflammation typically mucosal sites such as induc-
ible gut-associated lymphoid tissue and bronchus-associated 
lymphoid tissue. ELF are characterized by development of HEV, 
aggregates of T and B  cells often with T/B segregation and, in 
the majority, follicular dendritic cell networks (16). Abundant 
antigen-presenting cells including B cells are found around HEV, 
suggesting that development of HEV contributes to ectopic 
GC formation by recruitment of peripheral blood B  cells and 
antigen-presenting cells (such as dendritic cells) to the ELF (13). 
ELF tend to be transient structures that are triggered by infection 
or immunization, which often resolve after antigen clearance 
(16). In autoimmune diseases, ELF most commonly are found in 
chronic inflammation and function to maintain the autoimmune 
pathophysiologies (17). Ectopic GC are found in inflamed tissues 
of autoimmune diseases including thymuses of MG, synovial tis-
sue of rheumatoid arthritis, salivary glands of Sjogren’s syndrome, 
thyroid of Hashimoto’s thyroiditis, and meninges of secondary 
progressive multiple sclerosis (16–18).
Our first patient had long history of glaucoma and right eye 
puffiness for 2 years associated with conjunctival mass before 
presentation with LETM. Her conjunctival mass showed reactive 
lymphoid hyperplasia histologically. This raises the possibility of 
glaucoma-related ocular surface disease with chronic inflam-
mation in the conjunctiva-associated lymphoid tissue (CALT) 
resulting in the hyperplastic lymphoid follicles. The frequency 
of orbital masses containing ELF detected in glaucoma or other 
ophthalmological diseases is unknown. CALT is physiologi-
cally a form of MALT described as eye-associated lymphoid 
tissue (EALT) (19). Various types of insults to the surface of 
the eye can lead to ocular surface diseases (OCDs) (20). OCDs 
are characterized by inflammation of the ocular surface with 
activation of immune cells in CALT contributing to numerous 
inflammatory cells infiltration, remodeling of the ocular surface 
epithelia, and EALT components (20). Glaucoma is a chronic 
progressive optic neuropathy characterized by irreversible loss 
of retinal ganglion cells and is known to cause OCD, described 
as glaucoma-related OSD (19). In addition, glaucoma-mediated 
optic nerve damage might lead to release of AQP4 and hence 
contribute to the development of AQP4 autoimmunity in our 
first patient.
Importantly, the first patient had right optic atrophy on MRI 
and prolonged right VEP suggestive of previous subclinical 
ON and the second patient had severe ON on presentation. 
We hypothesize that for both patients, previous subclinical ON 
led to optic nerve damage with release of AQP4 to adjacent 
inflamed regions as optic nerve expresses high level of AQP4. 
This is followed by formation of ELF with ectopic GC around 
the eyeballs under the effects of proinflammatory cytokines 
and chemokines released during ON. Important cytokines and 
chemokines involved in the formation of ELF containing GC 
include IL-17, IL-21, IL-22, IL-27, CXCL13, CCL19, CCL21, 
and CXCL12 (16,  21–25), which play key roles in migration 
of antigen-presenting cells (dendritic cells), B and T cells into 
the ELF, aggregation of B and T cells and their segregation in 
different zones of the GC for functioning (21). Follicular den-
dritic cells play key roles in the formation of ectopic GC as they 
produce CXCL13 (21), the important chemokine for migration 
of TFH cells toward B  cell follicles as they express high level 
of CXCR5 and respond to CXCL13 (26). TFH cells belong to 
a highly specialized CD4+ memory T  cell subset essential for 
regulation of B cell activation, antibody affinity maturation, and 
GC reaction via the expression of surface receptors including 
inducible T-cell costimulator (ICOS) and programme cell death 
protein 1 (24, 27, 28). IL-21 is the main soluble cytokine released 
by TFH cells and IL-21/IL-21 receptor signaling in B cells pro-
vides strong stimuli for B  cell survival, proliferation, and dif-
ferentiation (29). In addition, Th17 cells have been reported to 
induce ELF containing GC in the CNS of experimental allergic 
encephalomyelitis, an animal model of multiple sclerosis (23). 
This was partly dependent on IL-17, which is also associated 
with survival and proliferation of B  cells (30). CXCL13 and 
CXCL12 regulate shuttling of B  cells within the ectopic GC. 
CXCL13 predominantly directs B cells to the light zone where 
antigen selection occurs whereas CXCL12 plays key role in 
migration of CXCR4high centroblasts to the dark zone where 
somatic hypermutation of B cell receptor occurs (21, 22). IL-27 
exerts inhibitory effect on formation and functioning of ectopic 
GC in animal models of autoimmune diseases including SLE 
and RA (30).
This is the first report of ectopic GC observed in AQP4-IgG 
positive NMOSD patients. Considering the presence of either 
active or chronic ON in the two patients on initial presentation, 
the orbital ectopic GC, which were in close proximity to the optic 
nerves in our two patients might be related to the development 
of AQP4 autoimmunity with production of AQP4-IgG and 
their severe myelitis and ON. Current evidence supports that 
in autoimmune diseases, ELF containing GC mostly develop in 
the context of chronic inflammation and contribute to maintain 
the disease process by acting as actively functioning GC where 
an antigen-driven selection process allows affinity maturation 
of B cells and differentiation to plasma cells capable of secret-
ing high-affinity autoantibodies specific for the autoantigens 
(21, 31). B cells of ELF in autoimmune diseases display highly 
somatically hypermutated immunoglobulin VH and VL regions 
consistent with a local antigen-driven process, and clonal 
diversification and differentiation to autoantibody-producing 
cells have been confirmed to occur within ELF by lineage tree 
analysis of immunoglobulin gene repertoire of B cells and plasma 
cells from ELF in autoimmune diseases (32–34). In addition, 
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